To assess the clinical significance of HER3 expression in TNBC, we then performed bioinformatics analyses of The Cancer Genome Atlas (TCGA) datasets to evaluate if HER3 mRNA expression would correlate with the clinical outcomes of breast cancer patients. Here, ERBB3 is linked to breast carcinoma.